Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drug
Alembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will depend on litigation outcome.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Diabetes | Diabetes Type 2 | Endocrinology | Legislation | Pharmaceuticals